1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. UNITY BIOTECHNOLOGY INC
Unity Biotechnology Inc XNAS: UNBX

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Unity Biotechnology Inc is on 13 Aug 2025 for the purpose of Unity Biotechnology Inc Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Unity Biotechnology Inc

The latest disclosure was made by Lynne Sullivan in Unity Biotechnology Inc where a trade of 21,867 Common Stock, $0.0001 par value done at an average price of $1.0 was reported to US exchanges on April 2, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lynne Sullivan CFO & Head of Corp. Dev. Sale of securities on an exchange or to another person at price $ 1.03 per share. 02 Apr 2025 21,867 98,905 (0%) 0% 1.0 22,523 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.03 per share. 02 Apr 2025 96,797 153,454 (0%) 0% 1.0 99,701 Common Stock, $0.0001 par value
Alexander Hieu Nguyen CLO and Head of Ops Sale of securities on an exchange or to another person at price $ 1.03 per share. 02 Apr 2025 17,852 48,753 (0%) 0% 1.0 18,388 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2025 65,000 120,772 (0%) 0% 0 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2025 106,000 106,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2025 286,000 286,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2025 175,000 250,251 (0%) 0% 0 Common Stock, $0.0001 par value
Alexander Hieu Nguyen CLO and Head of Ops Sale of securities on an exchange or to another person at price $ 1.16 per share. 27 Mar 2025 1,954 22,605 (0%) 0% 1.2 2,267 Common Stock, $0.0001 par value
Alexander Hieu Nguyen CLO and Head of Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2025 73,000 73,000 - - Stock Option (Right to Buy)
Alexander Hieu Nguyen CLO and Head of Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2025 44,000 66,605 (0%) 0% 0 Common Stock, $0.0001 par value
Yehia Hashad Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2025 20,000 20,000 - - Stock Option (Right to Buy)
Lynne Sullivan CFO & Head of Corp. Dev. Sale of securities on an exchange or to another person at price $ 2.23 per share. 04 Feb 2025 153 55,772 (0%) 0% 2.2 341 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.23 per share. 04 Feb 2025 642 75,251 (0%) 0% 2.2 1,432 Common Stock, $0.0001 par value
Alexander Hieu Nguyen CLO and Head of Ops Sale of securities on an exchange or to another person at price $ 2.23 per share. 04 Feb 2025 164 24,559 (0%) 0% 2.2 366 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 150,000 150,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 450,000 450,000 - - Stock Option (Right to Buy)
Alexander Hieu Nguyen CLO and Head of Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 150,000 150,000 - - Stock Option (Right to Buy)
Federico Grossi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 150,000 150,000 - - Stock Option (Right to Buy)
Lynne Sullivan CFO & Head of Corp. Dev. 04 Nov 2024 136 55,925 (0%) 0% 1.3 175 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 04 Nov 2024 432 75,893 (0%) 0% 1.3 557 Common Stock, $0.0001 par value
Alexander Hieu Nguyen Chief Legal Officer 04 Nov 2024 149 24,723 (0%) 0% 1.3 192 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. 02 Aug 2024 139 56,061 (0%) 0% 1.5 213 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 02 Aug 2024 604 76,325 (0%) 0% 1.5 924 Common Stock, $0.0001 par value
Alexander Hieu Nguyen Chief Legal Officer 02 Aug 2024 154 24,872 (0%) 0% 1.5 236 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. 25 Jun 2024 324 32,685 (0%) 0% 1.4 454 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 25 Jun 2024 1,214 76,929 (0%) 0% 1.4 1,700 Common Stock, $0.0001 par value
Alexander Hieu Nguyen Chief Legal Officer 25 Jun 2024 78 25,026 (0%) 0% 1.4 109 Common Stock, $0.0001 par value
Paul L. Berns Director 21 Jun 2024 10,000 10,000 - - Stock Option (Right to Buy)
Keith R. Leonard Director 21 Jun 2024 10,000 10,000 - - Stock Option (Right to Buy)
Camille D. Samuels Director 21 Jun 2024 10,000 10,000 - - Stock Option (Right to Buy)
Nathaniel E. David Director 21 Jun 2024 10,000 10,000 - - Stock Option (Right to Buy)
Margo R. Roberts Director 21 Jun 2024 10,000 10,000 - - Stock Option (Right to Buy)
Michael P. Samar Director 21 Jun 2024 10,000 10,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 02 May 2024 603 78,143 (0%) 0% 1.6 935 Common Stock, $0.0001 par value
Alexander Hieu Nguyen Chief Legal Officer 26 Mar 2024 20,000 25,104 (0%) 0% 0 Common Stock, $0.0001 par value
Alexander Hieu Nguyen Chief Legal Officer 26 Mar 2024 30,000 30,000 - - Stock Option (Right to Buy)
Ghosh Anirvan Director, Chief Executive Officer 02 Feb 2024 680 78,746 (0%) 0% 1.7 1,163 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 30 Jan 2024 1,183 79,426 (0%) 0% 1.7 2,023 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 02 Aug 2023 581 83,468 (0%) 0% 2.9 1,708 Common Stock, $0.0001 par value
Anirvan Ghosh Chief Executive Officer 31 Jul 2023 1,020 84,049 (0%) 0% 2.9 2,917 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 26 Jun 2023 1,177 85,069 (0%) 0% 3.2 3,766 Common Stock, $0.0001 par value
Paul L. Berns Director 23 Jun 2023 6,000 6,000 - - Stock Option (Right to Buy)
Keith R. Leonard Director 23 Jun 2023 6,000 6,000 - - Stock Option (Right to Buy)
Camille D. Samuels Director 23 Jun 2023 6,000 6,000 - - Stock Option (Right to Buy)
Nathaniel E. David Director 23 Jun 2023 6,000 6,000 - - Stock Option (Right to Buy)
Margo R. Roberts Director 23 Jun 2023 6,000 6,000 - - Stock Option (Right to Buy)
Michael P. Samar Director 23 Jun 2023 6,000 6,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 14 Jun 2023 1,212 86,246 (0%) 0% 3.4 4,109 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 02 May 2023 588 87,458 (0%) 0% 2.2 1,276 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 01 May 2023 1,020 88 (0%) 0% 2.2 2,193 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.70 per share. 31 Mar 2023 420 62,817 (0%) 0% 1.7 714 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 31 Mar 2023 1,959 89,066 (0%) 0% 1.7 3,330 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.00 per share. 14 Mar 2023 1,005 63,237 (0%) 0% 4 4,020 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 14 Mar 2023 1,210 91,025 (0%) 0% 4 4,840 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.84 per share. 02 Feb 2023 863 64,242 (0%) 0% 4.8 4,177 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 02 Feb 2023 2,573 92,235 (0%) 0% 4.8 12,453 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 30 Jan 2023 1,140 94,808 (0%) 0% 4.5 5,073 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.85 per share. 14 Dec 2022 1,016 65,105 (0%) 0% 2.9 2,896 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 14 Dec 2022 1,274 95,948 (0%) 0% 2.9 3,631 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. 18 Nov 2022 80,000 80,000 - - Stock Option (Right to Buy)
Lynne Sullivan CFO & Head of Corp. Dev. 18 Nov 2022 925 33,009 (0%) 0% 6.9 6,373 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 65,000 65,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 18 Nov 2022 200,000 200,000 - - Stock Option (Right to Buy)
Alexander Hieu Nguyen See Remarks 18 Nov 2022 65,000 65,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 03 Nov 2022 1,099 97,222 (0%) 0% 2.4 2,638 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.48 per share. 14 Sep 2022 10,923 661,213 (1%) 0% 0.5 5,243 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 14 Sep 2022 13,706 983,210 (2%) 0% 0.5 6,579 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 01 Aug 2022 10,446 996,916 (2%) 0% 0.7 6,999 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.59 per share. 27 Jun 2022 4,398 672,136 (1%) 0% 0.6 2,595 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 27 Jun 2022 12,149 1,007,362 (2%) 0% 0.6 7,168 Common Stock, $0.0001 par value
Paul L. Berns Director 24 Jun 2022 25,000 25,000 - - Stock Option (Right to Buy)
Keith R. Leonard Director 24 Jun 2022 25,000 25,000 - - Stock Option (Right to Buy)
Camille D. Samuels Director 24 Jun 2022 25,000 25,000 - - Stock Option (Right to Buy)
Nathaniel E. David Director 24 Jun 2022 25,000 25,000 - - Stock Option (Right to Buy)
Margo R. Roberts Director 24 Jun 2022 25,000 25,000 - - Stock Option (Right to Buy)
Michael P. Samar Director 24 Jun 2022 2,055 2,055 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.62 per share. 21 Jun 2022 3,697 676,534 (1%) 0% 0.6 2,292 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. 14 Jun 2022 10,530 680,231 (1%) 0% 0.6 6,634 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 14 Jun 2022 12,683 1,019,511 (2%) 0% 0.6 7,990 Common Stock, $0.0001 par value
Michael P. Samar Director 25 May 2022 50,000 50,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 02 May 2022 7,729 1,032,194 (2%) 0% 0.9 6,802 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. 31 Mar 2022 4,188 690,761 (1%) 0% 1.1 4,774 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 31 Mar 2022 14,472 1,039,923 (2%) 0% 1.1 16,498 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.88 per share. 14 Mar 2022 10,581 694,949 (1%) 0% 0.9 9,311 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 14 Mar 2022 9,272 1,054,395 (2%) 0% 0.9 8,159 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. 09 Feb 2022 50,000 326,785 (0%) 0% 0 Common Stock, $0.0001 par value
Lynne Sullivan CFO & Head of Corp. Dev. 09 Feb 2022 200,000 200,000 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2022 183,333 183,333 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2022 45,833 705,530 (1%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 09 Feb 2022 566,667 566,667 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 09 Feb 2022 141,667 1,063,667 (2%) 0% 0 Common Stock, $0.0001 par value
Alexander Hieu Nguyen See Remarks 09 Feb 2022 183,333 183,333 - - Stock Option (Right to Buy)
Alexander Hieu Nguyen See Remarks 09 Feb 2022 45,833 51,041 (0%) 0% 0 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. 14 Dec 2021 10,614 659,697 (1%) 0% 1.6 17,301 Common Stock, $0.0001 par value
Graham K. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
Paul L. Berns Director 24 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
Keith R. Leonard Director 24 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
Camille D. Samuels Director 24 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
Nathaniel David Director 24 Jun 2021 11,918 11,918 - - Stock Option (Right to Buy)
Kristina Burow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
Margo R. Roberts Director 24 Jun 2021 25,000 25,000 - - Stock Option (Right to Buy)
Lynne Sullivan CFO & Head of Corp. Dev. 24 Jun 2021 123,333 123,333 - - Stock Option (Right to Buy)
Lynne Sullivan CFO & Head of Corp. Dev. 24 Jun 2021 30,833 270,833 (0%) 0% 0 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 100,000 100,000 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2021 25,000 710,875 (1%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 24 Jun 2021 72,000 922,000 (2%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 24 Jun 2021 290,000 290,000 - - Stock Option (Right to Buy)
Alexander Hieu Nguyen See Remarks 24 Jun 2021 5,208 5,208 (0%) 0% 0 Common Stock, $0.0001 par value
Alexander Hieu Nguyen See Remarks 24 Jun 2021 20,833 20,833 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.18 per share. 21 Jun 2021 3,515 685,875 (1%) 0% 4.2 14,693 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.73 per share. 30 Mar 2021 2,829 689,390 (1%) 0% 5.7 16,210 Common Stock, $0.0001 par value
Alexander Hieu Nguyen See Remarks 09 Mar 2021 250,000 250,000 - - Stock Option (Right to Buy)
Nathaniel David Director 29 Jan 2021 50,000 50,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 29 Jan 2021 250,000 850,000 (1%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 29 Jan 2021 150,000 150,000 - - Stock Option (Right to Buy)
Nathaniel David Director, President 16 Dec 2020 1,700,000 624,703 (1%) 3% 5.2 8,908,000 Common Stock, $0.0001 par value
Lynne Sullivan Chief Financial Officer 13 Sep 2020 240,000 240,000 (0%) 0% 0 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Sep 2020 240,000 692,219 (1%) 0% 0 Common Stock, $0.0001 par value
Alexander Azoy See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Sep 2020 135,000 135,000 (0%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 13 Sep 2020 250,000 250,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 13 Sep 2020 300,000 600,000 (1%) 0% 0 Common Stock, $0.0001 par value
Lynne Sullivan See Remarks 01 Aug 2020 240,000 240,000 - - Stock Option (Right to Buy)
Keith R. Leonard Director 22 Jun 2020 4,711 89,546 (0%) 0% 9.7 45,555 Common Stock, $0.0001 par value
Tamara Tompkins See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.67 per share. 22 Jun 2020 2,483 42,847 (0%) 0% 9.7 24,011 Common Stock, $0.0001 par value
Nathaniel David Director, President 22 Jun 2020 2,483 2,324,703 (5%) 0% 9.7 24,011 Common Stock, $0.0001 par value
Daniel G. Marquess Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.67 per share. 22 Jun 2020 2,483 380,690 (0%) 0% 9.7 24,011 Common Stock, $0.0001 par value
Robert C. Goeltz Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.67 per share. 22 Jun 2020 2,483 161,027 (0%) 0% 9.7 24,011 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.67 per share. 22 Jun 2020 2,483 452,219 (0%) 0% 9.7 24,011 Common Stock, $0.0001 par value
Graham K. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 25,000 25,000 - - Stock Option (Right to Buy)
Robert T. Nelsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 25,000 25,000 - - Stock Option (Right to Buy)
Paul L. Berns Director 18 Jun 2020 25,000 25,000 - - Stock Option (Right to Buy)
Keith R. Leonard Director 18 Jun 2020 50,000 50,000 - - Stock Option (Right to Buy)
Camille D. Samuels Director 18 Jun 2020 25,000 25,000 - - Stock Option (Right to Buy)
Kristina Burow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 25,000 25,000 - - Stock Option (Right to Buy)
Margo R. Roberts Director 18 Jun 2020 25,000 25,000 - - Stock Option (Right to Buy)
David L. Lacey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 25,000 25,000 - - Stock Option (Right to Buy)
Nathaniel David Director, President 05 Jun 2020 3,200 2,327,186 (5%) 0% 8.9 28,478 Common Stock, $0.0001 par value
Tamara Tompkins See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 98,490 98,490 - - Stock Option (Right to Buy)
Tamara Tompkins See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 24,255 45,330 (0%) 0% 0 Common Stock, $0.0001 par value
Nathaniel David Director, President 30 Mar 2020 24,255 2,323,986 (5%) 0% 0 Common Stock, $0.0001 par value
Nathaniel David Director, President 30 Mar 2020 98,490 98,490 - - Stock Option (Right to Buy)
Daniel G. Marquess Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 98,490 98,490 - - Stock Option (Right to Buy)
Daniel G. Marquess Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 24,255 381,297 (0%) 0% 0 Common Stock, $0.0001 par value
Robert C. Goeltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 118,188 118,188 - - Stock Option (Right to Buy)
Robert C. Goeltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 29,106 163,510 (0%) 0% 0 Common Stock, $0.0001 par value
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 98,490 98,490 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2020 24,255 454,702 (0%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 30 Mar 2020 30,000 30,000 (0%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 30 Mar 2020 150,000 300,000 (0%) 0% 0 Common Stock, $0.0001 par value
Anirvan Ghosh Director, Chief Executive Officer 30 Mar 2020 800,000 800,000 - - Stock Option (Right to Buy)
Anirvan Ghosh Director, Chief Executive Officer 30 Mar 2020 120,000 150,000 (0%) 0% 0 Common Stock, $0.0001 par value
Keith R. Leonard Director, Chief Executive Officer 31 Dec 2019 383,475 0 (0%) 0% 0 Common Stock, $0.0001 par value
Keith R. Leonard Director, Chief Executive Officer 31 Dec 2019 116,525 94,257 (0%) 0% 0 Common Stock, $0.0001 par value
Keith R. Leonard Director, Chief Executive Officer 31 Dec 2019 500,000 500,000 (1%) 1% 0 Common Stock, $0.0001 par value
Keith R. Leonard Chief Executive Officer 19 Sep 2019 35,525 35,525 - - Stock Option (Right to Buy)
Tamara Tompkins See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2019 19,068 19,068 - - Stock Option (Right to Buy)
Nathaniel E. David Director, President 19 Sep 2019 27,825 27,825 - - Stock Option (Right to Buy)
Robert C. Goeltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2019 28,814 28,814 - - Stock Option (Right to Buy)
Graham K. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 25,000 25,000 - - Stock Option (Right to Buy)
Robert Taylor Nelsen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 25,000 25,000 - - Stock Option (Right to Buy)
Paul L. Berns Director 20 Jun 2019 25,000 25,000 - - Stock Option (Right to Buy)
Keith R. Leonard Director, Chief Executive Officer 20 Jun 2019 40,000 210,782 (0%) 0% 0 Common Stock
Keith R. Leonard Director, Chief Executive Officer 20 Jun 2019 260,000 260,000 - - Stock Option (Right to Buy)
Camille D. Samuels Director 20 Jun 2019 25,000 25,000 - - Stock Option (Right to Buy)
Tamara Tompkins See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 21,075 21,075 (0%) 0% 0 Common Stock
Tamara Tompkins See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 106,800 106,800 - - Stock Option (Right to Buy)
Nathaniel E. David Director, President 20 Jun 2019 106,800 106,800 - - Stock Option (Right to Buy)
Nathaniel E. David Director, President 20 Jun 2019 21,075 2,299,731 (5%) 0% 0 Common Stock
Kristina M. Burow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 25,000 25,000 - - Stock Option (Right to Buy)
Margo R. Roberts Director 20 Jun 2019 25,000 25,000 - - Stock Option (Right to Buy)
Daniel G. Marquess Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 21,075 357,041 (0%) 0% 0 Common Stock
Daniel G. Marquess Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 106,800 106,800 - - Stock Option (Right to Buy)
Robert C. Goeltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 116,850 116,850 - - Stock Option (Right to Buy)
Robert C. Goeltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 21,075 124,404 (0%) 0% 0 Common Stock
David L. Lacey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 25,000 25,000 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 106,800 106,800 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2019 21,075 430,447 (0%) 0% 0 Common Stock
Keith R. Leonard Director, Chief Executive Officer 19 Jun 2019 20,000 1,364,100 - - Stock Option (Right to Buy)
Keith R. Leonard Director, Chief Executive Officer 19 Jun 2019 20,000 170,782 (0%) 0% 3.4 68,000 Common Stock
Margo R. Roberts None 03 Dec 2018 50,661 50,661 - - Stock Option (right to buy)
Robert C. Goeltz Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.43 per share. 10 Oct 2018 5,000 101,348 (0%) 0% 3.4 17,150 Common Stock, $0.0001 par value
Robert C. Goeltz Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Oct 2018 5,000 120,620 - - Stock Option (Right to Buy)
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 195,672 1,682,417 (4%) 0% 0 Common Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 2,030,625 0 - - Series A-1 Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 4,228,432 0 - - Series A-2 Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 2,067,160 0 - - Series B Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 1,486,745 0 - - Series B Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 195,672 0 - - Series C Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 2,030,625 2,070,172 (4%) 4% 0 Common Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 2,067,160 8,365,764 (19%) 4% 0 Common Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 1,486,745 1,486,745 (3%) 3% 0 Common Stock
Robert T. Nelsen Director, Ten Percent Owner 07 May 2018 4,228,432 6,298,604 (15%) 10% 0 Common Stock
Paul L. Berns None 07 May 2018 3,261 3,261 (0%) 0% 0 Common Stock
Paul L. Berns None 07 May 2018 3,261 0 - - Series C Preferred Stock
Keith R. Leonard Director, Chief Executive Officer 07 May 2018 383,475 383,475 (0%) 0% 0 Common Stock
Keith R. Leonard Director, Chief Executive Officer 07 May 2018 1,630 150,782 (0%) 0% 0 Common Stock
Keith R. Leonard Director, Chief Executive Officer 07 May 2018 148,448 148,448 (0%) 0% 0 Common Stock
Keith R. Leonard Director, Chief Executive Officer 07 May 2018 1,630 0 - - Series C Preferred Stock
Keith R. Leonard Director, Chief Executive Officer 07 May 2018 148,448 0 - - Series B Preferred Stock
Keith R. Leonard Director, Chief Executive Officer 07 May 2018 383,475 0 - - Series B Preferred Stock
Nathaniel David Director, President 07 May 2018 222,148 2,277,026 (5%) 0% 0 Common Stock
Nathaniel David Director, President 07 May 2018 1,630 0 - - Series C Preferred Stock
Nathaniel David Director, President 07 May 2018 222,148 0 - - Series B Preferred Stock
Nathaniel David Director, President 07 May 2018 1,074,032 0 - - Series A-2 Preferred Stock
Nathaniel David Director, President 07 May 2018 1,630 2,278,656 (5%) 0% 0 Common Stock
Nathaniel David Director, President 07 May 2018 1,074,032 2,054,878 (4%) 2% 0 Common Stock
Kristina Burow None 07 May 2018 195,672 0 - - Series C Preferred Stock
Kristina Burow None 07 May 2018 1,486,745 0 - - Series B Preferred Stock
Kristina Burow None 07 May 2018 2,067,160 0 - - Series B Preferred Stock
Kristina Burow None 07 May 2018 4,228,432 0 - - Series A-2 Preferred Stock
Kristina Burow None 07 May 2018 2,067,160 8,365,764 (19%) 4% 0 Common Stock
Kristina Burow None 07 May 2018 1,486,745 1,486,745 (3%) 3% 0 Common Stock
Kristina Burow None 07 May 2018 2,030,625 0 - - Series A-1 Preferred Stock
Kristina Burow None 07 May 2018 2,030,625 2,070,172 (4%) 4% 0 Common Stock
Kristina Burow None 07 May 2018 4,228,432 6,298,604 (15%) 10% 0 Common Stock
Kristina Burow None 07 May 2018 195,672 1,682,417 (4%) 0% 0 Common Stock
Robert C. Goeltz Chief Financial Officer 07 May 2018 1,630 0 - - Series C Preferred Stock
Robert C. Goeltz Chief Financial Officer 07 May 2018 1,630 96,348 (0%) 0% 0 Common Stock
Jamie Dananberg Chief Medical Officer 07 May 2018 74,048 0 - - Series B Preferred Stock
Jamie Dananberg Chief Medical Officer 07 May 2018 1,630 0 - - Series C Preferred Stock
Jamie Dananberg Chief Medical Officer 07 May 2018 74,048 407,742 (0%) 0% 0 Common Stock
Jamie Dananberg Chief Medical Officer 07 May 2018 1,630 409,372 (0%) 0% 0 Common Stock
Graham K. Cooper None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2018 10,169 10,169 - - Stock Option (Right to Buy)
Robert T. Nelsen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2018 40,678 40,678 - - Stock Option (Right to Buy)
Keith R. Leonard Director, Chief Executive Officer 02 May 2018 67,797 67,797 - - Stock Option (Right to Buy)
Camille D. Samuels None 02 May 2018 40,678 40,678 - - Stock Option (Right to Buy)
Tamara Tompkins Corporate Secretary and GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2018 30,508 30,508 - - Stock Option (Right to Buy)
Nathaniel David Director, President 02 May 2018 47,458 47,458 - - Stock Option (Right to Buy)
Kristina Burow None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2018 40,678 40,678 - - Stock Option (Right to Buy)
Daniel G. Marquess Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2018 30,508 30,508 - - Stock Option (Right to Buy)
Robert C. Goeltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2018 30,508 30,508 - - Stock Option (Right to Buy)
Jamie Dananberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2018 30,508 30,508 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters